Legal Status

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.

The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.

The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.

Legal Status

Notice

Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Cancellation

A Notice by the Food and Drug Administration on 07/11/2013

Document Details
Published Content - Document Details

Agencies

Department of Health and Human Services

Food and Drug Administration

Agency/Docket Number

Docket No. FDA-2013-N-0001

Document Citation

78 FR 41803

Document Number

2013-16621

Document Type

Notice

Page

41803 (1 page)

Publication Date

07/11/2013

Published Content - Document Details

PDF
Official Content
- View printed version (PDF)
Official Content
Document Details
Published Content - Document Details

Agencies

Department of Health and Human Services

Food and Drug Administration

Agency/Docket Number

Docket No. FDA-2013-N-0001

Document Citation

78 FR 41803

Document Number

2013-16621

Document Type

Notice

Page

41803 (1 page)

Publication Date

07/11/2013

Published Content - Document Details
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the headings within the legal text of Federal Register documents. This repetition of headings to form internal navigation links has no substantive legal effect.
Enhanced Content - Table of Contents

Related Documents

Enhanced Content - Related Documents

FederalRegister.gov uses the agency dockets published with the document to display related documents.

Docket No. FDA-2013-N-0001 (130 Documents)
Date		Action	Title
	02/05/2014	Notice.	Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting
	02/03/2014	Notice of public workshop.	American Glaucoma Society/Food and Drug Administration Workshop on Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery; Public Workshop
	01/21/2014	Notice.	Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Device Good Manufacturing Practice Advisory Committee
	01/14/2014	Notice.	Pediatric Advisory Committee; Notice of Meeting
	01/13/2014	Notice.	Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Pharmacy Compounding Advisory Committee
	01/13/2014	Notice.	Request for Nominations for a Voting Consumer Representative on the Pharmacy Compounding Advisory Committee and Request for Notification From Consumer Organizations Interested in Participating in the Selection Process for Nominations for a Voting Consumer Representative on the Pharmacy Compounding Advisory Committee
	01/13/2014	Notice.	Request for Nominations for Voting Members on a Public Advisory Committee; Pharmacy Compounding Advisory Committee
	01/03/2014	Notice.	Risk Communications Advisory Committee; Notice of Meeting
	12/31/2013	Notice.	Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting
	12/30/2013	Notice of public workshop.	Strategies To Address Hemolytic Complications of Immune Globulin Infusions; Public Workshop
	12/26/2013	Notice.	Allergenic Products Advisory Committee; Notice of Meeting
	12/24/2013	Notice.	Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	12/24/2013	Notice.	Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	12/24/2013	Notice.	Science Advisory Board to the National Center for Toxicological Research; Notice of Meeting
	12/19/2013	Notice.	Food and Drug Administration/American Academy of Ophthalmology Workshop on Developing Novel Endpoints for Premium Intraocular Lenses; Public Workshop
	12/17/2013	Notice.	Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting
	12/17/2013	Notice.	Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting
	12/17/2013	Notice.	Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting
	11/27/2013	Notice.	Risk Communications Advisory Committee; Notice of Meeting
	11/25/2013	Notice of public meeting; correction.	Medical Gas Regulation Review; Announcement of Public Meeting; Correction
	11/20/2013	Notice of public workshop.	Changing Regulatory and Reimbursement Paradigms for Medical Devices in the Treatment of Obesity and Metabolic Diseases: How To Estimate and Reward True Patient-Centric Value in Innovation; Public Workshop
	11/12/2013	Notice.	Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	11/12/2013	Notice.	Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
	11/08/2013	Notice of public workshop.	Sixth Annual Sentinel Initiative; Public Workshop
	11/07/2013	Notice.	Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	11/04/2013	Notice.	Allergenic Products Advisory Committee; Notice of Meeting
	11/01/2013	Notice of public meeting.	Medical Gas Regulation Review; Announcement of Public Meeting
	10/30/2013	Notice.	Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
	10/30/2013	Notice.	Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Joint Meeting
	10/29/2013	Notice.	Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee
	10/25/2013	Notice.	Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Tobacco Products Scientific Advisory Committee
	10/24/2013	Notice.	Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting
	10/24/2013	Notice.	Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting
	10/23/2013	Notice.	Ear, Nose and Throat Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	10/23/2013	Notice.	Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting
	10/23/2013	Notice.	Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
	10/23/2013	Notice.	Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting
	10/02/2013	Notice.	Vaccines and Related Biological Products Advisory Committee; Notice of Meeting
	09/23/2013	Notice.	Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting
	09/23/2013	Notice.	Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting
	09/23/2013	Notice of public workshop.	Clinical Trial Design for Intravenous Fat Emulsion Products; Public Workshop
	09/17/2013	Notice.	Antiviral Drugs Advisory Committee; Notice of Meeting
	09/16/2013	Notice.	Blood Products Advisory Committee; Notice of Meeting
	09/16/2013	Notice.	Antiviral Drugs Advisory Committee; Notice of Meeting
	09/13/2013	Notice of public workshop.	Challenging Regulatory and Reimbursement Paradigms for Medical Devices in the Treatment of Metabolic Diseases: How to Estimate and Reward True Patient-Centric Value in Innovation; Public Workshop
	09/11/2013	Notice of public workshop.	Society of Clinical Research Associates-Food and Drug Administration: Food and Drug Administration Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice; Public Workshop
	09/09/2013	Notice.	Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	09/06/2013	Notice of public workshop.	Food and Drug Administration/American Academy of Ophthalmology Workshop on Developing Novel Endpoints for Premium Intraocular Lenses; Public Workshop
	09/05/2013	Notice.	Allergenic Products Advisory Committee; Notice of Meeting
	08/21/2013	Notice of public workshop.	The Food and Drug Administration/European Medicines Agency Orphan Product Designation and Grant Public Workshop
	08/19/2013	Notice.	Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
	08/14/2013	Notice of public workshop.	Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics; Public Workshop
	08/13/2013	Notice.	Pediatric Advisory Committee; Notice of Meeting
	08/13/2013	Notice.	Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	08/09/2013	Notice.	Anti-Infective Drugs Advisory Committee; Notice of Meeting
	08/09/2013	Notice of meeting.	Food and Drug Administration Patient Network Annual Meeting; Demystifying Food and Drug Administration: An Exploration of Drug Development Hosted by the Food and Drug Administration Office of Health and Constituent Affairs, Formerly the Office of Special Health Issues
	08/09/2013	Notice.	Oncologic Drugs Advisory Committee; Notice of Meeting
	08/08/2013	Notice.	Pediatric Ethics Subcommittee of the Pediatric Advisory Committee; Notice of Meeting
	08/07/2013	Notice.	Anti-Infective Drugs Advisory Committee; Notice of Meeting
	08/02/2013	Notice.	Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	08/02/2013	Notice.	Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting
	07/31/2013	Notice of public workshop.	Trial Designs and Endpoints for Liver Disease Secondary to Nonalcoholic Steatohepatitis; Public Workshop
	07/24/2013	Notice of conference.	Third Annual Food and Drug Administration Health Professional Organizations Conference
	07/23/2013	Notice.	Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting
	07/23/2013	Notice.	Food Advisory Committee; Notice of Meeting
	07/22/2013	Notice of public workshop.	Synergizing Efforts in Standards Development for Cellular Therapies and Regenerative Medicine Products; Public Workshop
	07/18/2013	Notice.	Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting
	07/15/2013	Notice.	Risk Communications Advisory Committee; Notice of Meeting
	07/15/2013	Notice.	Anesthetic and Analgesic Drug Products Advisory Committee; Cancellation
	07/11/2013	Notice.	Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Cancellation
	06/27/2013	Notice.	Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting
	06/26/2013	Notice.	Blood Products Advisory Committee; Notice of Meeting
	06/25/2013	Notice.	Tobacco Products Scientific Advisory Committee; Notice of Meeting
	06/24/2013	Notice.	Joint Meeting of the Risk Communication Advisory Committee and Tobacco Products Scientific Advisory Committee; Notice of Joint Meeting
	06/24/2013	Notice.	Nonprescription Drugs Advisory Committee; Notice of Meeting
	06/21/2013	Notice.	Request for Nominations for Voting and/or Nonvoting Consumer Representatives on Public Advisory Committees or Panels and Request for Notification From Consumer Organizations Interested in Participating in the Selection Process for Nominations for Voting and/or Nonvoting Consumer Representatives on Public Advisory Committees or Panels
	06/19/2013	Notice.	Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting
	06/19/2013	Notice of public workshop.	Rechanneling the Current Cardiac Risk Paradigm: Arrhythmia Risk Assessment During Drug Development Without the Thorough QT Study; Public Workshop
	06/04/2013	Notice.	Arthritis Advisory Committee; Notice of Meeting
	05/30/2013	Notice.	Arthritis Advisory Committee; Notice of Meeting
	05/23/2013	Notice.	General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	05/23/2013	Notice.	Drug Safety and Risk Management Advisory Committee; Notice of Meeting
	05/22/2013	Notice.	Science Board to the Food and Drug Administration; Notice of Meeting
	05/21/2013	Notice.	Request for Nominations for Voting Members on Public Advisory Panels or Committees
	05/17/2013	Notice.	Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting
	05/10/2013	Notice.	Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting
	05/08/2013	Notice.	Microbiology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	05/06/2013	Notice of public conference.	Food and Drug Administration/International Society for Pharmaceutical Engineering Co-Sponsorship Educational Workshop: Redefining the `C' in CGMP (Current Good Manufacturing Practices): Creating, Implementing, and Sustaining a Culture of Quality
	05/02/2013	Notice.	Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	04/15/2013	Notice.	Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting
	04/04/2013	Notice of public conference.	2013 Parenteral Drug Association/Food and Drug Administration Joint Regulatory Conference: Driving Quality and Compliance Throughout the Product Life Cycle in a Global Regulatory Environment
	04/04/2013	Notice.	Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee; Amendment of Notice
	04/02/2013	Notice; correction.	Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee: Notice of Change of Meeting Schedule
View More Docket Documents

Enhanced Content - Related Documents

Public Comments
Enhanced Content - Public Comments

This feature is not available for this document.

Enhanced Content - Public Comments
Regulations.gov Data
Enhanced Content - Regulations.gov Data

Additional information is not currently available for this document.

Enhanced Content - Regulations.gov Data
Sharing
Enhanced Content - Sharing

Shorter Document URL

https://www.federalregister.gov/d/2013-16621

Email

Email this document to a friend

Enhanced Content - Sharing
Print
Enhanced Content - Print
- Print this document
Enhanced Content - Print
Document Statistics
Enhanced Content - Document Statistics

Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.

Page views

99 as of 08/07/2026 at 6:15 am EDT

Enhanced Content - Document Statistics
Other Formats
Enhanced Content - Other Formats

This document is also available in the following formats:

JSON

Normalized attributes and metadata

XML

Original full text XML

MODS

Government Publishing Office metadata

More information and documentation can be found in our developer tools pages.

Enhanced Content - Other Formats
Public Inspection
Public Inspection

This PDF is FR Doc. 2013-16621 as it appeared on Public Inspection on 07/10/2013 at 8:45 am.

If you are using public inspection listings for legal research, you should verify the contents of the documents against a final, official edition of the Federal Register. Only official editions of the Federal Register provide legal notice of publication to the public and judicial notice to the courts under 44 U.S.C. 1503 & 1507. Learn more here.

Public Inspection

Published Document: 2013-16621 (78 FR 41803)

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings

Document headings vary by document type but may contain the following:

the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions

See the Document Drafting Handbook for more details.

Department of Health and Human Services

Food and Drug Administration

[Docket No. FDA-2013-N-0001]

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The meeting of the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee scheduled for July 24 and 25, 2013, is cancelled. This meeting was announced in the Federal Register of April 25, 2013 (78 FR 24426).

FOR FURTHER INFORMATION CONTACT:

Sara J. Anderson, Center for Devices and Radiological Health, Food and Drug Administration,10903 New Hampshire Ave., Bldg. 66, rm. 1611, Silver Spring, MD 20993, 301-796-7047, Sara.Anderson@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting.

Dated: July 5, 2013.

Leslie Kux,

Assistant Commissioner for Policy.

[FR Doc. 2013-16621 Filed 7-10-13; 8:45 am]

BILLING CODE 4160-01-P

Published Document: 2013-16621 (78 FR 41803)

Notice

Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Cancellation

Department of Health and Human Services

Food and Drug Administration

AGENCY:

ACTION:

SUMMARY:

FOR FURTHER INFORMATION CONTACT:

Home

Sections

Browse

Search

Reader Aids

My FR

Information